Compare BKTI & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BKTI | PROK |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 284.7M | 331.2M |
| IPO Year | 2000 | 2021 |
| Metric | BKTI | PROK |
|---|---|---|
| Price | $83.63 | $2.15 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $74.00 | $7.40 |
| AVG Volume (30 Days) | 23.3K | ★ 838.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 446.15 | N/A |
| EPS | ★ 2.38 | N/A |
| Revenue | ★ $74,094,000.00 | $76,000.00 |
| Revenue This Year | $12.00 | $1,010.19 |
| Revenue Next Year | $11.30 | N/A |
| P/E Ratio | $35.96 | ★ N/A |
| Revenue Growth | ★ 45.42 | N/A |
| 52 Week Low | $26.20 | $0.46 |
| 52 Week High | $89.23 | $7.13 |
| Indicator | BKTI | PROK |
|---|---|---|
| Relative Strength Index (RSI) | 59.17 | 53.77 |
| Support Level | $73.89 | $2.09 |
| Resistance Level | $85.06 | $2.58 |
| Average True Range (ATR) | 3.92 | 0.16 |
| MACD | 0.43 | 0.03 |
| Stochastic Oscillator | 84.24 | 87.44 |
BK Technologies Corp a holding company, operates through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.